Allos Ventures is pleased to announce the final closing of Allos II, a $40 million venture capital fund targeting investments in early-stage technology companies in the Midwest. Allos II is led by Don Aquilano, John McIlwraith, and Dov Rosenberg and builds on the success of our first fund, which invested in AssureRx Health, BidPal Networks, Scale Computing, and Weblink International.
The investment strategy of Allos II continues the successful Allos I strategy, including:
- Industry Focus. Companies in high-growth sectors where the managing directors have operating and investing experience – primarily software and technology-enabled business services, but also specialty healthcare providers, later-stage medical devices and diagnostics, and advanced manufacturing. No pharmaceutical or biotechnology companies.
- Stage Focus. Early-stage companies with a validated product/service and revenue beyond the pilot/beta stage but which are a year or more from sustained profitability. Preference for investments in first institutional financing rounds. No start-ups.
- Geographic Focus. Companies within a four-hour drive of Cincinnati or Indianapolis, which better enables us to support portfolio companies.
- Investment Size. Initial investments in companies are expected to be approximately $2 million, in rounds between $3 and $6 million, with reserves for follow-on investments. As the lead investor, Allos will develop syndicates that include other early-stage venture capital funds and individuals with industry expertise.
We and our portfolio companies benefit from an advisory board and limited partner group that includes successful technology company founders and executives such as David Becker (First Internet Bank of Indiana), Scott Dorsey (Exact Target), Bill Godfrey (Aprimo), Ray Henderson (Blackboard), Mark Hill (Baker Hill), Scott Jones (Boston Technology, Gracenote, Cha Cha), Bill Oesterle (Angie’s List), and Carl Sparks (Travelocity), among others.
For more information, visit www.allosventures.com or contact any of us.